Us Bancorp \De\ Geron Corp Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Geron Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 21,007 shares of GERN stock, worth $58,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,007
Previous 18,296
14.82%
Holding current value
$58,609
Previous $83,000
10.84%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding GERN
# of Institutions
287Shares Held
493MCall Options Held
1.87MPut Options Held
690K-
Black Rock Inc. New York, NY46.6MShares$130 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$123 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$93.6 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$90.1 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$80.8 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.05B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...